Rapid DNA technology featured on CSI: Crime Scene Investigation is being utilized by forensic labs and law enforcement agencies worldwide
PLEASANTON, California – November 5, 2013 – IntegenX Inc., the leading developer of Rapid DNA human identification technology, today announced that the RapidHIT™ System will be starring in the November 6th episode of the long-running, forensic science-based television show CSI: Crime Scene Investigation. In episode 7, “Under A Cloud”, investigators will be racing against the clock to track a perpetrator, with the RapidHIT System as a critical technology to solve the crime.
CSI: Crime Scene Investigation writers make great efforts to research the latest cutting-edge forensic tools and technologies and ensure the show is representing the latest innovations. In episode 7, the RapidHIT System is deployed in a mobile crime scene vehicle, an actual scenario at a major law enforcement agency today. According to Sheila Thomas, Product Integration Specialist for the show, “Our technical advisors were contacted by various law enforcement agencies about the RapidHIT System. It’s simple to use, providing accurate results in 90 minutes. Without the RapidHIT System we could not have developed the storyline.”
While the story is fictional, the commercially available RapidHIT System is helping law enforcement agencies solve real crimes around the world. The RapidHIT System fully automates and integrates all steps necessary to generate a DNA profile with less than five minutes of hands-on time. “We’re thrilled that the producers have chosen to premiere the RapidHIT on their show. It’s a testament to the system’s ability to combine ease of use with rapid turnaround time providing an invaluable impact toward solving crimes quickly, and ensuring the safety of communities worldwide”, commented Robert Schueren, President, Chief Executive Officer of IntegenX.
About IntegenX Inc.
IntegenX, headquartered in Pleasanton, California, is a leading developer of rapid human DNA identification technology. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing, forensics, and biodefense applications. For more information, please visit www.integenx.com.
IntegenX, the IntegenX logo, and RapidHIT are trademarks of IntegenX Inc. All other names or trademarks are the property of their respective owners.
David V. Smith
Chief Operating Officer
5720 Stoneridge Drive, Suite 300
Pleasanton, CA 94588